Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study)
This study aimed to identify heart failure (HF) subphenotypes using 92 repeatedly measured circulating proteins in 250 patients with heart failure with reduced ejection fraction, and to investigate their clinical characteristics and prognosis. Clinical data and blood samples were collected tri-month...
Saved in:
Published in: | International journal of cardiology Vol. 364; pp. 77 - 84 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier B.V
01-10-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | This study aimed to identify heart failure (HF) subphenotypes using 92 repeatedly measured circulating proteins in 250 patients with heart failure with reduced ejection fraction, and to investigate their clinical characteristics and prognosis.
Clinical data and blood samples were collected tri-monthly until the primary endpoint (PEP) or censoring occurred, with a maximum of 11 visits. The Olink Cardiovascular III panel was measured in baseline samples and the last two samples before the PEP (in 66 PEP cases), or the last sample before censoring (in 184 PEP-free patients). The PEP comprised cardiovascular death, heart transplantation, Left Ventricular Assist Device implantation, and hospitalization for HF. Cluster analysis was performed on individual biomarker trajectories to identify subphenotypes. Then biomarker profiles and clinical characteristics were investigated, and survival analysis was conducted.
Clustering revealed three clinically diverse subphenotypes. Cluster 3 was older, with a longer duration of, and more advanced HF, and most comorbidities. Cluster 2 showed increasing levels over time of most biomarkers. In cluster 3, there were elevated baseline levels and increasing levels over time of 16 remaining biomarkers. Median follow-up was 2.2 (1.4–2.5) years. Cluster 3 had a significantly poorer prognosis compared to cluster 1 (adjusted event-free survival time ratio 0.25 (95%CI:0.12–0.50), p < 0.001). Repeated measurements clusters showed incremental prognostic value compared to clusters using single measurements, or clinical characteristics only.
Clustering based on repeated biomarker measurements revealed three clinically diverse subphenotypes, of which one has a significantly worse prognosis, therefore contributing to improved (individualized) prognostication.
•We repeatedly measured 92 circulating proteins in 250 ambulant patients with HFrEF.•Clustering of individual biomarker trajectories identified 3 HFrEF subphenotypes.•Subphenotypes were clinically diverse and associated with adverse events.•Thus temporal biomarker pattern subphenotypes may aid in personalized prognostication. |
---|---|
AbstractList | This study aimed to identify heart failure (HF) subphenotypes using 92 repeatedly measured circulating proteins in 250 patients with heart failure with reduced ejection fraction, and to investigate their clinical characteristics and prognosis.
Clinical data and blood samples were collected tri-monthly until the primary endpoint (PEP) or censoring occurred, with a maximum of 11 visits. The Olink Cardiovascular III panel was measured in baseline samples and the last two samples before the PEP (in 66 PEP cases), or the last sample before censoring (in 184 PEP-free patients). The PEP comprised cardiovascular death, heart transplantation, Left Ventricular Assist Device implantation, and hospitalization for HF. Cluster analysis was performed on individual biomarker trajectories to identify subphenotypes. Then biomarker profiles and clinical characteristics were investigated, and survival analysis was conducted.
Clustering revealed three clinically diverse subphenotypes. Cluster 3 was older, with a longer duration of, and more advanced HF, and most comorbidities. Cluster 2 showed increasing levels over time of most biomarkers. In cluster 3, there were elevated baseline levels and increasing levels over time of 16 remaining biomarkers. Median follow-up was 2.2 (1.4–2.5) years. Cluster 3 had a significantly poorer prognosis compared to cluster 1 (adjusted event-free survival time ratio 0.25 (95%CI:0.12–0.50), p < 0.001). Repeated measurements clusters showed incremental prognostic value compared to clusters using single measurements, or clinical characteristics only.
Clustering based on repeated biomarker measurements revealed three clinically diverse subphenotypes, of which one has a significantly worse prognosis, therefore contributing to improved (individualized) prognostication.
•We repeatedly measured 92 circulating proteins in 250 ambulant patients with HFrEF.•Clustering of individual biomarker trajectories identified 3 HFrEF subphenotypes.•Subphenotypes were clinically diverse and associated with adverse events.•Thus temporal biomarker pattern subphenotypes may aid in personalized prognostication. BACKGROUNDThis study aimed to identify heart failure (HF) subphenotypes using 92 repeatedly measured circulating proteins in 250 patients with heart failure with reduced ejection fraction, and to investigate their clinical characteristics and prognosis. METHODSClinical data and blood samples were collected tri-monthly until the primary endpoint (PEP) or censoring occurred, with a maximum of 11 visits. The Olink Cardiovascular III panel was measured in baseline samples and the last two samples before the PEP (in 66 PEP cases), or the last sample before censoring (in 184 PEP-free patients). The PEP comprised cardiovascular death, heart transplantation, Left Ventricular Assist Device implantation, and hospitalization for HF. Cluster analysis was performed on individual biomarker trajectories to identify subphenotypes. Then biomarker profiles and clinical characteristics were investigated, and survival analysis was conducted. RESULTSClustering revealed three clinically diverse subphenotypes. Cluster 3 was older, with a longer duration of, and more advanced HF, and most comorbidities. Cluster 2 showed increasing levels over time of most biomarkers. In cluster 3, there were elevated baseline levels and increasing levels over time of 16 remaining biomarkers. Median follow-up was 2.2 (1.4-2.5) years. Cluster 3 had a significantly poorer prognosis compared to cluster 1 (adjusted event-free survival time ratio 0.25 (95%CI:0.12-0.50), p < 0.001). Repeated measurements clusters showed incremental prognostic value compared to clusters using single measurements, or clinical characteristics only. CONCLUSIONSClustering based on repeated biomarker measurements revealed three clinically diverse subphenotypes, of which one has a significantly worse prognosis, therefore contributing to improved (individualized) prognostication. |
Author | van Ramshorst, Jan Rizopoulos, Dimitris Akkerhuis, K. Martijn Germans, Tjeerd de Lange, Iris Constantinescu, Alina A. Umans, Victor A.W.M. Manintveld, Olivier C. Petersen, Teun B. Caliskan, Kadir Kardys, Isabella de Bakker, Marie Boersma, Eric Brugts, Jasper J. |
Author_xml | – sequence: 1 givenname: Iris surname: de Lange fullname: de Lange, Iris organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 2 givenname: Teun B. surname: Petersen fullname: Petersen, Teun B. organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 3 givenname: Marie surname: de Bakker fullname: de Bakker, Marie organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 4 givenname: K. Martijn surname: Akkerhuis fullname: Akkerhuis, K. Martijn organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 5 givenname: Jasper J. surname: Brugts fullname: Brugts, Jasper J. organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 6 givenname: Kadir surname: Caliskan fullname: Caliskan, Kadir organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 7 givenname: Olivier C. surname: Manintveld fullname: Manintveld, Olivier C. organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 8 givenname: Alina A. surname: Constantinescu fullname: Constantinescu, Alina A. organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 9 givenname: Tjeerd surname: Germans fullname: Germans, Tjeerd organization: Department of Cardiology, Northwest Clinics, Alkmaar, the Netherlands – sequence: 10 givenname: Jan surname: van Ramshorst fullname: van Ramshorst, Jan organization: Department of Cardiology, Northwest Clinics, Alkmaar, the Netherlands – sequence: 11 givenname: Victor A.W.M. surname: Umans fullname: Umans, Victor A.W.M. organization: Department of Cardiology, Northwest Clinics, Alkmaar, the Netherlands – sequence: 12 givenname: Eric surname: Boersma fullname: Boersma, Eric organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 13 givenname: Dimitris surname: Rizopoulos fullname: Rizopoulos, Dimitris organization: Department of Biostatistics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands – sequence: 14 givenname: Isabella surname: Kardys fullname: Kardys, Isabella email: i.kardys@erasmusmc.nl organization: Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands |
BookMark | eNp9kcFu1DAQhi1UJLalb8DBx3JIsBMn8V6QoKIsUiUOtGfLHs9qvWTj4HEW7Yv0eet2OXOaOXzfL838l-xiihMy9kGKWgrZf9rXYQ82-boRTVOLvhaNeMNWUg-qkkOnLtiqYEPVNUP7jl0S7YUQar3WK_a0QZsy39owLgk5LW7e4RTzaUbizhJ6HieecEaby-5CPNj0GxM_oKViHHDKxG1RLVGE8Er9DXnHYQxTADty2NlkIWMKlAMUePLc-iMmQo7HV__ma4jVr024e-CUF3_6-J693dqR8PrfvGKPd98ebjfV_c_vP26_3FfQ6i5XVkndik6hbgYJDlvlPKCwfY8gVOd0o9zg5NoDCClAaYGd906A7mDbDq69Yjfn3DnFPwtSNodAgONoJ4wLmaYftGqFVqqg6oxCikQJt2ZOoTzjZKQwLzWYvTnXYF5qMKI3pYaifT5rWM44BkyGIOAE6ENCyMbH8P-AZwrLmDo |
CitedBy_id | crossref_primary_10_1161_JAHA_123_031646 crossref_primary_10_1007_s11897_023_00615_z |
Cites_doi | 10.1016/j.ahj.2017.10.008 10.1016/j.ejheart.2008.08.005 10.1016/j.amjcard.2006.01.059 10.1093/bib/bbr042 10.1093/eurjhf/hfp029 10.1093/eurheartj/ehab368 10.1161/HHF.0b013e318291329a 10.1016/j.jacc.2014.07.979 10.1038/srep43328 10.1242/dev.017863 10.1080/1354750X.2020.1727015 10.1016/j.kint.2017.09.013 10.1210/jc.2018-01241 10.1161/CIRCRESAHA.118.314338 10.1093/eurheartj/ehy712 10.1002/ejhf.2169 10.1161/CIRCULATIONAHA.114.010637 10.18637/jss.v061.i06 10.1016/j.jmva.2007.07.002 10.1006/bbrc.1999.1469 10.1016/j.jchf.2019.09.009 10.1016/j.ijcard.2017.02.078 10.1161/CIRCULATIONAHA.104.500546 10.1016/j.csda.2006.11.025 10.1016/j.ccep.2015.08.001 10.1093/bioinformatics/btw313 10.1161/CIR.0000000000000490 10.1016/j.hfc.2021.02.009 10.15420/cfr.2016:25:2 10.1016/j.ghir.2011.04.003 10.1161/JAHA.118.009555 10.1016/j.jchf.2018.03.006 |
ContentType | Journal Article |
Copyright | 2022 The Authors |
Copyright_xml | – notice: 2022 The Authors |
DBID | 6I. AAFTH AAYXX CITATION 7X8 |
DOI | 10.1016/j.ijcard.2022.06.020 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1874-1754 |
EndPage | 84 |
ExternalDocumentID | 10_1016_j_ijcard_2022_06_020 S0167527322009196 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 0SF 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 6I. 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABBQC ABFNM ABJNI ABLJU ABLVK ABMAC ABMZM ABOCM ABYKQ ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM LCYCR M29 M41 MO0 N9A O-L O9- OA. OAUVE OL~ OZT P-8 P-9 P2P PC. Q38 ROL RPZ SAE SCC SDF SDG SEL SES SPCBC SSH SSZ T5K UV1 Z5R ZA5 ~G- .55 .GJ 29J AAQXK AAXKI AAYXX ABXDB ADMUD ADVLN AFFNX AFJKZ AGHFR AKRWK ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB G-2 HEB HMK HMO HVGLF HZ~ NCXOZ R2- RIG SEW WUQ X7M ZGI 7X8 |
ID | FETCH-LOGICAL-c385t-a4183054e8271cbe34bdce0a66ec045b824b7b19dcc010c480e5ddb0c85cf37b3 |
ISSN | 0167-5273 |
IngestDate | Fri Oct 25 02:17:45 EDT 2024 Thu Sep 26 18:03:15 EDT 2024 Fri Feb 23 02:40:23 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Heart failure Cluster analysis Biomarkers Phenotype Prognosis Repeated measurements |
Language | English |
License | This is an open access article under the CC BY license. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c385t-a4183054e8271cbe34bdce0a66ec045b824b7b19dcc010c480e5ddb0c85cf37b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://dx.doi.org/10.1016/j.ijcard.2022.06.020 |
PQID | 2678430844 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2678430844 crossref_primary_10_1016_j_ijcard_2022_06_020 elsevier_sciencedirect_doi_10_1016_j_ijcard_2022_06_020 |
PublicationCentury | 2000 |
PublicationDate | 2022-10-01 2022-10-00 20221001 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | International journal of cardiology |
PublicationYear | 2022 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Chow, Maisel, Anand, Bozkurt, de Boer, Felker (bb0080) 2017; 135 Olink [Internet] (bb0120) 2021 Jerke, Marino, Daumke, Kettritz (bb0185) 2017; 7 Organization WH [Internet] (bb0130) 2021 Van Buuren (bb0165) 2018 Charrad, Ghazzali, Boiteau, Niknafs (bb0140) 2014; 61 van Boven, Akkerhuis, Anroedh, Rizopoulos, Pinto, Battes (bb0105) 2017; 235 Mann, Bristow (bb0035) 2005; 111 Hartigan (bb0155) 1979; 28 van Boven, Battes, Akkerhuis, Rizopoulos, Caliskan, Anroedh (bb0110) 2018; 196 Najafi, Jamrozik, Dobson (bb0015) 2009; 11 R Core Team [Internet] (bb0175) 2021 Gu, Eils, Schlesner (bb0160) 2016; 32 Brandt, Lundell, Brismar (bb0180) 2011; 21 Tominaga, Kuroiwa, Tago, Iwahana, Yanagisawa, Komatsu (bb0200) 1999; 264 Brankovic, Akkerhuis, Mouthaan, Brugts, Manintveld, van Ramshorst (bb0095) 2018; 103 van Buuren, Groothuis-Oudshoorn (bb0170) 2011; 45 Hennig (bb0145) 2007; 52 Writing Group for the Division of Cardiovascular Sciences’ Strategic Vision Implementation P, Goff, Buxton, Pearson, Wei, Gosselin (bb0070) 2019; 124 Bouwens, Brankovic, Mouthaan, Baart, Rizopoulos, van Boven (bb0090) 2019; 8 Savarese, Lund (bb0010) 2017; 3 Andreas A [Internet] (bb0135) 2019 McDonagh, Metra, Adamo, Gardner, Baumbach, Bohm (bb0030) 2021; 42 Ferrario, Strawn (bb0040) 2006; 98 Gaudet, Livstone, Lewis, Thomas (bb0190) 2011; 12 Stienen, Ferreira, Kobayashi, Preud’homme, Dobre, Machu (bb0065) 2020; 25 Mazurek, Jessup (bb0075) 2015; 7 Brankovic, Akkerhuis, van Boven, Anroedh, Constantinescu, Caliskan (bb0100) 2018; 93 Dickstein, Cohen-Solal, Filippatos, McMurray, Ponikowski, Poole-Wilson (bb0115) 2008; 10 Tromp, Ouwerkerk, Demissei, Anker, Cleland, Dickstein (bb0060) 2018; 39 Heidenreich, Albert, Allen, Bluemke, Butler, Fonarow (bb0005) 2013; 6 Tsao, Lyass, Enserro, Larson, Ho, Kizer (bb0020) 2018; 6 Shah, Katz, Selvaraj, Burke, Yancy, Gheorghiade (bb0055) 2015; 131 Uijl, Savarese, Vaartjes, Dahlstrom, Brugts, Linssen (bb0085) 2021; 23 Krause, Liepke, Meyer, Adermann, Forssmann, Maronde (bb0195) 2001; 6 BioXpedia [Internet] (bb0125) 2021 Cohen, Schrauben, Zhao, Basso, Cvijic, Li (bb0045) 2020; 8 El-Bizri, Guignabert, Wang, Cheng, Stankunas, Chang (bb0205) 2008; 135 Ahmad, Pencina, Schulte, O’Brien, Whellan, Pina (bb0025) 2014; 64 Sorimachi, Omote, Borlaug (bb0050) 2021; 17 Hennig (bb0150) 2008; 99 van Buuren (10.1016/j.ijcard.2022.06.020_bb0170) 2011; 45 Chow (10.1016/j.ijcard.2022.06.020_bb0080) 2017; 135 Mazurek (10.1016/j.ijcard.2022.06.020_bb0075) 2015; 7 Sorimachi (10.1016/j.ijcard.2022.06.020_bb0050) 2021; 17 Tsao (10.1016/j.ijcard.2022.06.020_bb0020) 2018; 6 Hennig (10.1016/j.ijcard.2022.06.020_bb0150) 2008; 99 Tromp (10.1016/j.ijcard.2022.06.020_bb0060) 2018; 39 Krause (10.1016/j.ijcard.2022.06.020_bb0195) 2001; 6 Shah (10.1016/j.ijcard.2022.06.020_bb0055) 2015; 131 Savarese (10.1016/j.ijcard.2022.06.020_bb0010) 2017; 3 McDonagh (10.1016/j.ijcard.2022.06.020_bb0030) 2021; 42 Brankovic (10.1016/j.ijcard.2022.06.020_bb0095) 2018; 103 BioXpedia [Internet] (10.1016/j.ijcard.2022.06.020_bb0125) Najafi (10.1016/j.ijcard.2022.06.020_bb0015) 2009; 11 R Core Team [Internet] (10.1016/j.ijcard.2022.06.020_bb0175) 2021 Bouwens (10.1016/j.ijcard.2022.06.020_bb0090) 2019; 8 Dickstein (10.1016/j.ijcard.2022.06.020_bb0115) 2008; 10 Tominaga (10.1016/j.ijcard.2022.06.020_bb0200) 1999; 264 Hennig (10.1016/j.ijcard.2022.06.020_bb0145) 2007; 52 van Boven (10.1016/j.ijcard.2022.06.020_bb0110) 2018; 196 Ahmad (10.1016/j.ijcard.2022.06.020_bb0025) 2014; 64 van Boven (10.1016/j.ijcard.2022.06.020_bb0105) 2017; 235 Van Buuren (10.1016/j.ijcard.2022.06.020_bb0165) 2018 Olink [Internet] (10.1016/j.ijcard.2022.06.020_bb0120) Uijl (10.1016/j.ijcard.2022.06.020_bb0085) 2021; 23 Heidenreich (10.1016/j.ijcard.2022.06.020_bb0005) 2013; 6 Hartigan (10.1016/j.ijcard.2022.06.020_bb0155) 1979; 28 Ferrario (10.1016/j.ijcard.2022.06.020_bb0040) 2006; 98 Charrad (10.1016/j.ijcard.2022.06.020_bb0140) 2014; 61 Organization WH [Internet] (10.1016/j.ijcard.2022.06.020_bb0130) Gaudet (10.1016/j.ijcard.2022.06.020_bb0190) 2011; 12 Mann (10.1016/j.ijcard.2022.06.020_bb0035) 2005; 111 Cohen (10.1016/j.ijcard.2022.06.020_bb0045) 2020; 8 Brandt (10.1016/j.ijcard.2022.06.020_bb0180) 2011; 21 Writing Group for the Division of Cardiovascular Sciences’ Strategic Vision Implementation P (10.1016/j.ijcard.2022.06.020_bb0070) 2019; 124 Gu (10.1016/j.ijcard.2022.06.020_bb0160) 2016; 32 Stienen (10.1016/j.ijcard.2022.06.020_bb0065) 2020; 25 El-Bizri (10.1016/j.ijcard.2022.06.020_bb0205) 2008; 135 Andreas A [Internet] (10.1016/j.ijcard.2022.06.020_bb0135) Brankovic (10.1016/j.ijcard.2022.06.020_bb0100) 2018; 93 Jerke (10.1016/j.ijcard.2022.06.020_bb0185) 2017; 7 |
References_xml | – volume: 25 start-page: 201 year: 2020 end-page: 211 ident: bb0065 article-title: Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (the metabolic road to diastolic heart failure) publication-title: Biomarkers. contributor: fullname: Machu – volume: 124 start-page: 491 year: 2019 end-page: 497 ident: bb0070 article-title: Implementing the National Heart, Lung, and Blood Institute’s strategic vision in the division of cardiovascular sciences publication-title: Circ. Res. contributor: fullname: Gosselin – volume: 61 start-page: 1 year: 2014 end-page: 36 ident: bb0140 article-title: Nbclust: an R package for determining the relevant number of clusters in a data set publication-title: J. Stat. Softw. contributor: fullname: Niknafs – volume: 42 start-page: 3599 year: 2021 end-page: 3726 ident: bb0030 article-title: 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure publication-title: Eur. Heart J. contributor: fullname: Bohm – volume: 7 start-page: 557 year: 2015 end-page: 575 ident: bb0075 article-title: Understanding heart failure publication-title: Card. Electrophysiol. Clin. contributor: fullname: Jessup – volume: 8 year: 2019 ident: bb0090 article-title: Temporal patterns of 14 blood biomarker candidates of cardiac remodeling in relation to prognosis of patients with chronic heart failure-the bio- SH i FT study publication-title: J. Am. Heart Assoc. contributor: fullname: van Boven – volume: 7 start-page: 43328 year: 2017 ident: bb0185 article-title: Characterization of the CD177 interaction with the ANCA antigen proteinase 3 publication-title: Sci. Rep. contributor: fullname: Kettritz – volume: 131 start-page: 269 year: 2015 end-page: 279 ident: bb0055 article-title: Phenomapping for novel classification of heart failure with preserved ejection fraction publication-title: Circulation. contributor: fullname: Gheorghiade – volume: 64 start-page: 1765 year: 2014 end-page: 1774 ident: bb0025 article-title: Clinical implications of chronic heart failure phenotypes defined by cluster analysis publication-title: J. Am. Coll. Cardiol. contributor: fullname: Pina – volume: 32 start-page: 2847 year: 2016 end-page: 2849 ident: bb0160 article-title: Complex heatmaps reveal patterns and correlations in multidimensional genomic data publication-title: Bioinformatics. contributor: fullname: Schlesner – volume: 11 start-page: 472 year: 2009 end-page: 479 ident: bb0015 article-title: Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure publication-title: Eur. J. Heart Fail. contributor: fullname: Dobson – volume: 52 start-page: 258 year: 2007 end-page: 271 ident: bb0145 article-title: Cluster-wise assessment of cluster stability publication-title: Comput. Stat. Data An. contributor: fullname: Hennig – year: 2018 ident: bb0165 article-title: Flexible Imputation of Missing Data contributor: fullname: Van Buuren – year: 2021 ident: bb0175 article-title: R: A Language and Environment for Statistical Computing contributor: fullname: R Core Team [Internet] – volume: 39 start-page: 4269 year: 2018 end-page: 4276 ident: bb0060 article-title: Novel endotypes in heart failure: effects on guideline-directed medical therapy publication-title: Eur. Heart J. contributor: fullname: Dickstein – volume: 21 start-page: 167 year: 2011 end-page: 173 ident: bb0180 article-title: Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, −2 and −4 publication-title: Growth Hormon. IGF Res. contributor: fullname: Brismar – year: 2021 ident: bb0120 article-title: Olink Target 96 Cardiovascular III contributor: fullname: Olink [Internet] – volume: 135 start-page: e1054 year: 2017 end-page: e1091 ident: bb0080 article-title: Role of biomarkers for the prevention, assessment, and Management of Heart Failure: a scientific statement from the American Heart Association publication-title: Circulation. contributor: fullname: Felker – volume: 111 start-page: 2837 year: 2005 end-page: 2849 ident: bb0035 article-title: Mechanisms and models in heart failure: the biomechanical model and beyond publication-title: Circulation. contributor: fullname: Bristow – volume: 99 start-page: 1154 year: 2008 end-page: 1176 ident: bb0150 article-title: Dissolution point and isolation robustness: robustness criteria for general cluster analysis methods publication-title: J. Multivar. Anal. contributor: fullname: Hennig – volume: 23 start-page: 973 year: 2021 end-page: 982 ident: bb0085 article-title: Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction publication-title: Eur. J. Heart Fail. contributor: fullname: Linssen – volume: 103 start-page: 3954 year: 2018 end-page: 3964 ident: bb0095 article-title: Cardiometabolic biomarkers and their temporal patterns predict poor outcome in chronic heart failure (bio-SHiFT study) publication-title: J. Clin. Endocrinol. Metab. contributor: fullname: van Ramshorst – year: 2019 ident: bb0135 article-title: robustHD: Robust Methods for High-Dimensional Data. R Package Version 0.6.1 contributor: fullname: Andreas A [Internet] – volume: 6 start-page: 215 year: 2001 end-page: 218 ident: bb0195 article-title: Human natriuretic peptides exhibit antimicrobial activity publication-title: Eur. J. Med. Res. contributor: fullname: Maronde – year: 2021 ident: bb0130 article-title: International Statistical Classification of Diseases and Related Health Problems (ICD) contributor: fullname: Organization WH [Internet] – volume: 45 start-page: 1 year: 2011 end-page: 67 ident: bb0170 article-title: Mice: multivariate imputation by chained equations in R publication-title: J. Stat. Softw. contributor: fullname: Groothuis-Oudshoorn – volume: 3 start-page: 7 year: 2017 end-page: 11 ident: bb0010 article-title: Global public health burden of heart failure publication-title: Card. Fail. Rev. contributor: fullname: Lund – volume: 196 start-page: 36 year: 2018 end-page: 48 ident: bb0110 article-title: Toward personalized risk assessment in patients with chronic heart failure: detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study publication-title: Am. Heart J. contributor: fullname: Anroedh – volume: 98 start-page: 121 year: 2006 end-page: 128 ident: bb0040 article-title: Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease publication-title: Am. J. Cardiol. contributor: fullname: Strawn – volume: 93 start-page: 952 year: 2018 end-page: 960 ident: bb0100 article-title: Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study publication-title: Kidney Int. contributor: fullname: Caliskan – volume: 235 start-page: 124 year: 2017 end-page: 132 ident: bb0105 article-title: Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: the Bio-SHiFT study publication-title: Int. J. Cardiol. contributor: fullname: Battes – volume: 10 start-page: 933 year: 2008 end-page: 989 ident: bb0115 article-title: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) publication-title: Eur. J. Heart Fail. contributor: fullname: Poole-Wilson – volume: 6 start-page: 606 year: 2013 end-page: 619 ident: bb0005 article-title: Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association publication-title: Circ. Heart Fail. contributor: fullname: Fonarow – volume: 8 start-page: 172 year: 2020 end-page: 184 ident: bb0045 article-title: Clinical Phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone publication-title: JACC Heart Fail. contributor: fullname: Li – volume: 135 start-page: 2981 year: 2008 end-page: 2991 ident: bb0205 article-title: SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis publication-title: Development. contributor: fullname: Chang – volume: 264 start-page: 14 year: 1999 end-page: 18 ident: bb0200 article-title: Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Komatsu – year: 2021 ident: bb0125 article-title: Olink Proteomics contributor: fullname: BioXpedia [Internet] – volume: 17 start-page: 483 year: 2021 end-page: 498 ident: bb0050 article-title: Clinical Phenogroups in heart failure with preserved ejection fraction publication-title: Heart Fail. Clin. contributor: fullname: Borlaug – volume: 6 start-page: 678 year: 2018 end-page: 685 ident: bb0020 article-title: Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction publication-title: JACC Heart Fail. contributor: fullname: Kizer – volume: 12 start-page: 449 year: 2011 end-page: 462 ident: bb0190 article-title: Phylogenetic-based propagation of functional annotations within the gene ontology consortium publication-title: Brief. Bioinform. contributor: fullname: Thomas – volume: 28 start-page: 100 year: 1979 end-page: 108 ident: bb0155 article-title: WMA. Algorithm AS 136: a K-means clustering algorithm publication-title: J. R. Stat. Soc.: Ser. C: Appl. Stat. contributor: fullname: Hartigan – volume: 196 start-page: 36 year: 2018 ident: 10.1016/j.ijcard.2022.06.020_bb0110 article-title: Toward personalized risk assessment in patients with chronic heart failure: detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study publication-title: Am. Heart J. doi: 10.1016/j.ahj.2017.10.008 contributor: fullname: van Boven – volume: 10 start-page: 933 issue: 10 year: 2008 ident: 10.1016/j.ijcard.2022.06.020_bb0115 publication-title: Eur. J. Heart Fail. doi: 10.1016/j.ejheart.2008.08.005 contributor: fullname: Dickstein – volume: 98 start-page: 121 issue: 1 year: 2006 ident: 10.1016/j.ijcard.2022.06.020_bb0040 article-title: Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease publication-title: Am. J. Cardiol. doi: 10.1016/j.amjcard.2006.01.059 contributor: fullname: Ferrario – volume: 28 start-page: 100 issue: 1 year: 1979 ident: 10.1016/j.ijcard.2022.06.020_bb0155 article-title: WMA. Algorithm AS 136: a K-means clustering algorithm publication-title: J. R. Stat. Soc.: Ser. C: Appl. Stat. contributor: fullname: Hartigan – volume: 12 start-page: 449 issue: 5 year: 2011 ident: 10.1016/j.ijcard.2022.06.020_bb0190 article-title: Phylogenetic-based propagation of functional annotations within the gene ontology consortium publication-title: Brief. Bioinform. doi: 10.1093/bib/bbr042 contributor: fullname: Gaudet – ident: 10.1016/j.ijcard.2022.06.020_bb0135 contributor: fullname: Andreas A [Internet] – volume: 6 start-page: 215 issue: 5 year: 2001 ident: 10.1016/j.ijcard.2022.06.020_bb0195 article-title: Human natriuretic peptides exhibit antimicrobial activity publication-title: Eur. J. Med. Res. contributor: fullname: Krause – volume: 11 start-page: 472 issue: 5 year: 2009 ident: 10.1016/j.ijcard.2022.06.020_bb0015 article-title: Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure publication-title: Eur. J. Heart Fail. doi: 10.1093/eurjhf/hfp029 contributor: fullname: Najafi – volume: 42 start-page: 3599 issue: 36 year: 2021 ident: 10.1016/j.ijcard.2022.06.020_bb0030 article-title: 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehab368 contributor: fullname: McDonagh – volume: 6 start-page: 606 issue: 3 year: 2013 ident: 10.1016/j.ijcard.2022.06.020_bb0005 article-title: Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association publication-title: Circ. Heart Fail. doi: 10.1161/HHF.0b013e318291329a contributor: fullname: Heidenreich – year: 2021 ident: 10.1016/j.ijcard.2022.06.020_bb0175 contributor: fullname: R Core Team [Internet] – volume: 64 start-page: 1765 issue: 17 year: 2014 ident: 10.1016/j.ijcard.2022.06.020_bb0025 article-title: Clinical implications of chronic heart failure phenotypes defined by cluster analysis publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2014.07.979 contributor: fullname: Ahmad – ident: 10.1016/j.ijcard.2022.06.020_bb0120 contributor: fullname: Olink [Internet] – volume: 7 start-page: 43328 year: 2017 ident: 10.1016/j.ijcard.2022.06.020_bb0185 article-title: Characterization of the CD177 interaction with the ANCA antigen proteinase 3 publication-title: Sci. Rep. doi: 10.1038/srep43328 contributor: fullname: Jerke – volume: 135 start-page: 2981 issue: 17 year: 2008 ident: 10.1016/j.ijcard.2022.06.020_bb0205 article-title: SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis publication-title: Development. doi: 10.1242/dev.017863 contributor: fullname: El-Bizri – volume: 25 start-page: 201 issue: 2 year: 2020 ident: 10.1016/j.ijcard.2022.06.020_bb0065 article-title: Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (the metabolic road to diastolic heart failure) publication-title: Biomarkers. doi: 10.1080/1354750X.2020.1727015 contributor: fullname: Stienen – volume: 93 start-page: 952 issue: 4 year: 2018 ident: 10.1016/j.ijcard.2022.06.020_bb0100 article-title: Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study publication-title: Kidney Int. doi: 10.1016/j.kint.2017.09.013 contributor: fullname: Brankovic – volume: 103 start-page: 3954 issue: 11 year: 2018 ident: 10.1016/j.ijcard.2022.06.020_bb0095 article-title: Cardiometabolic biomarkers and their temporal patterns predict poor outcome in chronic heart failure (bio-SHiFT study) publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2018-01241 contributor: fullname: Brankovic – volume: 124 start-page: 491 issue: 4 year: 2019 ident: 10.1016/j.ijcard.2022.06.020_bb0070 article-title: Implementing the National Heart, Lung, and Blood Institute’s strategic vision in the division of cardiovascular sciences publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.118.314338 contributor: fullname: Writing Group for the Division of Cardiovascular Sciences’ Strategic Vision Implementation P – volume: 39 start-page: 4269 issue: 48 year: 2018 ident: 10.1016/j.ijcard.2022.06.020_bb0060 article-title: Novel endotypes in heart failure: effects on guideline-directed medical therapy publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehy712 contributor: fullname: Tromp – volume: 23 start-page: 973 issue: 6 year: 2021 ident: 10.1016/j.ijcard.2022.06.020_bb0085 article-title: Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction publication-title: Eur. J. Heart Fail. doi: 10.1002/ejhf.2169 contributor: fullname: Uijl – year: 2018 ident: 10.1016/j.ijcard.2022.06.020_bb0165 contributor: fullname: Van Buuren – volume: 45 start-page: 1 issue: 3 year: 2011 ident: 10.1016/j.ijcard.2022.06.020_bb0170 article-title: Mice: multivariate imputation by chained equations in R publication-title: J. Stat. Softw. contributor: fullname: van Buuren – volume: 131 start-page: 269 issue: 3 year: 2015 ident: 10.1016/j.ijcard.2022.06.020_bb0055 article-title: Phenomapping for novel classification of heart failure with preserved ejection fraction publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.114.010637 contributor: fullname: Shah – volume: 61 start-page: 1 issue: 6 year: 2014 ident: 10.1016/j.ijcard.2022.06.020_bb0140 article-title: Nbclust: an R package for determining the relevant number of clusters in a data set publication-title: J. Stat. Softw. doi: 10.18637/jss.v061.i06 contributor: fullname: Charrad – volume: 99 start-page: 1154 issue: 6 year: 2008 ident: 10.1016/j.ijcard.2022.06.020_bb0150 article-title: Dissolution point and isolation robustness: robustness criteria for general cluster analysis methods publication-title: J. Multivar. Anal. doi: 10.1016/j.jmva.2007.07.002 contributor: fullname: Hennig – volume: 264 start-page: 14 issue: 1 year: 1999 ident: 10.1016/j.ijcard.2022.06.020_bb0200 article-title: Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1999.1469 contributor: fullname: Tominaga – volume: 8 start-page: 172 issue: 3 year: 2020 ident: 10.1016/j.ijcard.2022.06.020_bb0045 article-title: Clinical Phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone publication-title: JACC Heart Fail. doi: 10.1016/j.jchf.2019.09.009 contributor: fullname: Cohen – volume: 235 start-page: 124 year: 2017 ident: 10.1016/j.ijcard.2022.06.020_bb0105 article-title: Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: the Bio-SHiFT study publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2017.02.078 contributor: fullname: van Boven – ident: 10.1016/j.ijcard.2022.06.020_bb0125 contributor: fullname: BioXpedia [Internet] – volume: 111 start-page: 2837 issue: 21 year: 2005 ident: 10.1016/j.ijcard.2022.06.020_bb0035 article-title: Mechanisms and models in heart failure: the biomechanical model and beyond publication-title: Circulation. doi: 10.1161/CIRCULATIONAHA.104.500546 contributor: fullname: Mann – volume: 52 start-page: 258 issue: 1 year: 2007 ident: 10.1016/j.ijcard.2022.06.020_bb0145 article-title: Cluster-wise assessment of cluster stability publication-title: Comput. Stat. Data An. doi: 10.1016/j.csda.2006.11.025 contributor: fullname: Hennig – volume: 7 start-page: 557 issue: 4 year: 2015 ident: 10.1016/j.ijcard.2022.06.020_bb0075 article-title: Understanding heart failure publication-title: Card. Electrophysiol. Clin. doi: 10.1016/j.ccep.2015.08.001 contributor: fullname: Mazurek – volume: 32 start-page: 2847 issue: 18 year: 2016 ident: 10.1016/j.ijcard.2022.06.020_bb0160 article-title: Complex heatmaps reveal patterns and correlations in multidimensional genomic data publication-title: Bioinformatics. doi: 10.1093/bioinformatics/btw313 contributor: fullname: Gu – volume: 135 start-page: e1054 issue: 22 year: 2017 ident: 10.1016/j.ijcard.2022.06.020_bb0080 article-title: Role of biomarkers for the prevention, assessment, and Management of Heart Failure: a scientific statement from the American Heart Association publication-title: Circulation. doi: 10.1161/CIR.0000000000000490 contributor: fullname: Chow – volume: 17 start-page: 483 issue: 3 year: 2021 ident: 10.1016/j.ijcard.2022.06.020_bb0050 article-title: Clinical Phenogroups in heart failure with preserved ejection fraction publication-title: Heart Fail. Clin. doi: 10.1016/j.hfc.2021.02.009 contributor: fullname: Sorimachi – volume: 3 start-page: 7 issue: 1 year: 2017 ident: 10.1016/j.ijcard.2022.06.020_bb0010 article-title: Global public health burden of heart failure publication-title: Card. Fail. Rev. doi: 10.15420/cfr.2016:25:2 contributor: fullname: Savarese – volume: 21 start-page: 167 issue: 3 year: 2011 ident: 10.1016/j.ijcard.2022.06.020_bb0180 article-title: Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, −2 and −4 publication-title: Growth Hormon. IGF Res. doi: 10.1016/j.ghir.2011.04.003 contributor: fullname: Brandt – volume: 8 issue: 4 year: 2019 ident: 10.1016/j.ijcard.2022.06.020_bb0090 article-title: Temporal patterns of 14 blood biomarker candidates of cardiac remodeling in relation to prognosis of patients with chronic heart failure-the bio- SH i FT study publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.118.009555 contributor: fullname: Bouwens – ident: 10.1016/j.ijcard.2022.06.020_bb0130 contributor: fullname: Organization WH [Internet] – volume: 6 start-page: 678 issue: 8 year: 2018 ident: 10.1016/j.ijcard.2022.06.020_bb0020 article-title: Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction publication-title: JACC Heart Fail. doi: 10.1016/j.jchf.2018.03.006 contributor: fullname: Tsao |
SSID | ssj0004998 |
Score | 2.424519 |
Snippet | This study aimed to identify heart failure (HF) subphenotypes using 92 repeatedly measured circulating proteins in 250 patients with heart failure with reduced... BACKGROUNDThis study aimed to identify heart failure (HF) subphenotypes using 92 repeatedly measured circulating proteins in 250 patients with heart failure... |
SourceID | proquest crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | 77 |
SubjectTerms | Biomarkers Cluster analysis Heart failure Phenotype Prognosis Repeated measurements |
Title | Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study) |
URI | https://dx.doi.org/10.1016/j.ijcard.2022.06.020 https://search.proquest.com/docview/2678430844 |
Volume | 364 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bi9NAFB66K4gv4hXvjOCDElJymVz6aLVLQdcHW0F8CZOZKSayydI0f8Xf6zlzSeLuihfwJZShSSc5X785c_Kdcwh5sWO8TEUS-lGaMZ8pzny-i6Qfp1IlXGZc6Tad60324XP-dsVWs5nr2TaO_VdLwxjYGjNn_8Law0VhAD6DzeEIVofjH9l9DTd08Ha8Qr251_UlirhajLR2Hi5ZEl8P7NU5cDA6n1V7hgKdvXc2Bgs7D-Vg3Bpu0Ke7HEpxRY1njn2dO-XpelA6kLusWn-zrk62poKtizjUo3J-DEROylcIrY-dhvql8t5jBoRms33VjWSOhUENa25V33jL-eSUJf9m9SKnGA0YcI2jX3tTWOHd3NNVFOpmGvuAbbNT0dmA3KWkHBMjBe7HunJmiTO8ngMSwVNiU-KPUzahbttNxjoB7MrlxUQ66nlV49OY45R09dcoGJfTQeS4wYngPCJ8AwVMd0SuRUCHyMZfko9j9u5Cd2wepu0SPLUK8fIv_cqBuuBKaP9oe4vctBsb-tog8jaZqeYOuX5qpRt3yXcNTGqBSX8CJtXApG1DHTDpAEw6BSYFYNIRmBSBSR0w6QVgUgAmtcCkBpj05QBLqmH56h75dLLavln7timIL-I8OficwSIE-wyVR1koShWzUgoV8DRVArYnZR6xMivDhRQiCAPB8kAlUpaByBOxi7Myvk-Om7ZRDwjFSJ5UIQujMmaLXcyjMMxkIjjwFPj1wUPiuyddnJvaL4UTRdaFsUyBlilQG4rfz5w5Cuu_Gr-0APz85sznznoF0Du-s-ONavuuAArNWRzkjD3656s_JjfGP88TcnzY9-opOepk_0wj8QfJ59GW |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Heart+failure+subphenotypes+based+on+repeated+biomarker+measurements+are+associated+with+clinical+characteristics+and+adverse+events+%28Bio-SHiFT+study%29&rft.jtitle=International+journal+of+cardiology&rft.au=de+Lange%2C+Iris&rft.au=Petersen%2C+Teun+B.&rft.au=de+Bakker%2C+Marie&rft.au=Akkerhuis%2C+K.+Martijn&rft.date=2022-10-01&rft.pub=Elsevier+B.V&rft.issn=0167-5273&rft.eissn=1874-1754&rft.volume=364&rft.spage=77&rft.epage=84&rft_id=info:doi/10.1016%2Fj.ijcard.2022.06.020&rft.externalDocID=S0167527322009196 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-5273&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-5273&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-5273&client=summon |